SCHEMBL23999983

SCHEMBL23999983

CC(=O)Nc1ccc(-c2nc3cc(Br)cnc3[nH]2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.55
KDM4E B2RXH2 7/20 0.55
HPGD P15428 6/20 0.55
TP53 P04637 5/20 0.55
HSD17B10 Q99714 4/20 0.55
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
TDP1 Q9NUW8 1/20 0.55
DYRK1A Q13627 1/20 0.53
DYRK1B Q9Y463 1/20 0.53
GAA P10253 1/20 0.50
MAPT P10636 3/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
SMN1; SMN2 Q16637 4/20 0.47
POLB P06746 2/20 0.47
BAZ1A Q9NRL2 1/20 0.46
HPSE Q9Y251 2/20 0.46
FGFR3 P22607 1/20 0.46
MMP2 P08253 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5260040 0.92 ALDH1A1 (0.48) ALDH1A1KDM4EHPGDTP53HSD17B10
SCHEMBL30563488 0.81 KDM4E (0.62) ALDH1A1KDM4EHPGDTP53HSD17B10
SCHEMBL25276426 0.81 KDM4E (0.62) ALDH1A1KDM4EHPGDTP53HSD17B10
SCHEMBL23999988 0.80 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDTP53HSD17B10
SCHEMBL3088868 0.80 MMP2 (0.65) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL4843914 0.80 KDR (0.57) ALDH1A1MEN1KMT2AMAPTNPC1
SCHEMBL4839487 0.80 TBK1 (0.45) TP53DYRK1ADYRK1BMAPT
SCHEMBL14861104 0.79 FGFR1 (0.46) ALDH1A1KDM4EHPGDTP53HSD17B10
SCHEMBL3063960 0.78 HPGD (0.48) ALDH1A1KDM4EHPGDTP53HSD17B10
SCHEMBL13607771 0.78 CHEK2 (0.53) ALDH1A1KDM4EHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 US disclosed
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed
WO-2023081854-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2023-05-11 WO disclosed
WO-2021226519-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2021-11-11 WO disclosed
WO-2021226517-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2021-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295114-A1 AKT3 MODULATORS AKT3, AKT2, MTOR ALDH1A1 4544/4885KDM4E 3961/4885HPGD 2437/4885
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR ALDH1A1 4541/4885KDM4E 4095/4885HPGD 2503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.